• Oncimmune to trial EarlyCDT-Lung test in China

  UK-based immunodiagnostics developer Oncimmune, in alliance with Genostics, has initiated a multi-centre clinical trial of...
  Read More...

• Nanodevices could be the answer to healing chronic wounds

  The wound care market is estimated to be worth $35.0 billion, and has been showing...
  Read More...

• Deals this week: Accuray, Thermo Fisher, Circassia

  Accuray has formed a joint venture (JV) with China Isotope and Radiation Corporation (CIRC) for...
  Read More...

• Ekso Bionics to form $100m exoskeleton products JV in China

  Exoskeleton solutions developer Ekso Bionics has agreed to form a joint venture (JV) with Zhejiang...
  Read More...

• Accuray forms JV to offer radiation oncology systems in China

  US-based radiotherapy systems developer Accuray has formed a joint venture (JV) with China Isotope and...
  Read More...

• Deals this week: Mobidiag, Garmin, ARANZ Medical

  Mobidiag has agreed to form a joint venture (JV) with Autobio Diagnostics for the commercialisation...
  Read More...

• Mobidiag and Autobio to commercialise Novodiag platform in China

  Finnish molecular diagnostics developer Mobidiag has signed an agreement with Chinese clinical diagnostics company Autobio...
  Read More...

• AI could revolutionise dermatology, but key hurdles remain

  The use of artificial intelligence (AI) in the field of dermatology could provide significant benefit...
  Read More...

• Samsung unveils new HERA W10 ultrasound device

  Medical equipment firm Samsung Medison has unveiled its new premium ultrasound system HERA W10 along...
  Read More...

• Deals this week: Myriad Genetics, Tencent, Stryker

  Myriad Genetics has added a commercialisation plan to its existing agreement with Pfizer.
  Read More...